Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan

Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan: First Amicus Medicine and First Oral Precision Medicine for Fabry Patients with an Amenable Mutation in Japan